The effect of metformin combined with liraglutide on gut microbiota of Chinese patients with type 2 diabetes

被引：0
|
作者：
Xiaohong Niu
Panpan Lu
Linqing Huang
Yan Sun
Miaomiao Jin
Jing Liu
Xing Li
机构：
[1] Changzhi Medical College Affiliated Heji Hospital,Department of Endocrinology
[2] Changzhi Medical College,Department of Endocrinology
[3] Second Hospital of Shanxi Medical University,Department of Endocrinology
来源：
International Microbiology | 2024年 / 27卷
关键词：
Glucagon-like peptide-1 agonist; Gut microbiota; Liraglutide; Metformin; Type-2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 276
页数：11
相关论文
共 50 条
  • [31] Metformin and gut microbiota: their interactions and their impact on diabetes
    Natalia G. Vallianou
    Theodora Stratigou
    Stylianos Tsagarakis
    Hormones, 2019, 18 : 141 - 144
  • [32] Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes
    Caesar, Robert
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (03) : 224 - 231
  • [33] Combined metformin and insulin therapy for patients with type 2 diabetes mellitus
    Ponssen, HH
    Elte, JWF
    Lehert, P
    Schouten, JP
    Bets, D
    CLINICAL THERAPEUTICS, 2000, 22 (06) : 709 - 718
  • [34] Effect of metformin on gut microbiota imbalance in patients with T2DM, and the value of probiotic supplementation
    Li, Lu
    Chen, Yanli
    Tang, Zhipeng
    You, Yan
    Guo, Yang
    Liao, Yong
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2024, 52 (04) : 84 - 90
  • [35] Analysis of the effect of liraglutide on glycemic variability in patients with type 2 diabetes
    Xing, Yuling
    Chen, Jinhu
    Zhao, Liying
    Ma, Huijuan
    ENDOCRINE JOURNAL, 2020, 67 (04) : 455 - 468
  • [36] Effect of Combination Treatment with Metformin and Probiotics Probio-Fit® on Clinical Symptoms and Gut Microbiota Structure in Type 2 Diabetes
    Chen Y.
    Wang Y.
    You L.
    Jin H.
    Zhang D.
    Li D.
    Zhang H.
    Journal of Chinese Institute of Food Science and Technology, 2019, 19 (04): : 16 - 26
  • [37] The mitigative effect of isorhamnetin against type 2 diabetes via gut microbiota regulation in mice
    Li, Jinjun
    Yuan, Huimin
    Zhao, Zhiqi
    Li, Li
    Li, Xiaoqiong
    Zhu, Liying
    Wang, Xin
    Sun, Ping
    Xiao, Yinping
    FRONTIERS IN NUTRITION, 2022, 9
  • [38] Effect of liraglutide on lipids in patients with type 2 diabetes: a pilot study
    Aoki, Kazutaka
    Kamiyama, Hiroshi
    Takihata, Masahiro
    Taguri, Masataka
    Shibata, Eriko
    Shinoda, Kazuaki
    Yoshii, Taishi
    Nakajima, Shigeru
    Terauchi, Yasuo
    ENDOCRINE JOURNAL, 2020, 67 (09) : 957 - 962
  • [39] New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes
    Chen, Yanxia
    Wang, Mian
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 4849 - 4863
  • [40] Renal Protective Effect of Metformin in Type 2 Diabetes Patients
    Wang, Hsi-Hao
    Lin, Sheng-Hsiang
    Hung, Shih-Yuan
    Chiou, Yuan-Yow
    Hsu, Wan-Chia
    Chang, Chih-Min
    Liou, Hung-Hsiang
    Chang, Min-Yu
    Ho, Li-Chun
    Wu, Ching-Fang
    Lee, Yi-Che
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025, 110 (05) : 1224 - 1234
12345